Printer's No. PN3411
See other bills
under the
same topic PRINTER'S NO. 3411 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.526 Session of 2026 INTRODUCED BY BELLMON, HOHENSTEIN, GIRAL, McNEILL, HILL-EVANS, VENKAT, KHAN, WAXMAN, SANCHEZ, NEILSON, CIRESI, GALLAGHER AND CEPEDA-FREYTIZ, MAY 13, 2026 REFERRED TO COMMITTEE ON HEALTH, MAY 14, 2026 A RESOLUTIONRecognizing the month of May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.WHEREAS, Guillain-Barré syndrome (GBS) is a rare acute autoimmune condition which affects an individual's peripheral nerves; andWHEREAS, GBS was first described in 1916 by scientists Guillain, Barré and Strohl and was believed to primarily affect the limbs; andWHEREAS, GBS is classified as an autoimmune disease due to the fact that the immune system attacks healthy nerves and damages them; andWHEREAS, GBS affects 3,000 to 6,000 people annually in the United States, according to the United States Centers for Disease Control and Prevention; andWHEREAS, GBS can affect anyone, however the disease typically affects male adults over 50 years of age; andWHEREAS, While the cause of GBS is not fully understood, 1234567891011121314151617 symptoms typically start shortly after a respiratory or gastrointestinal bacterial or viral infection; andWHEREAS, GBS is not contagious and is characterized by a rapid onset of symptoms, which typically increase in severity over the course of the syndrome; andWHEREAS, Due to the risk of muscle paralysis, GBS usually requires hospitalization; andWHEREAS, Those with GBS are typically able to fully recover with immunotherapy treatments and rehabilitation; andWHEREAS, The National Institutes of Health's National Institute of Neurological Disorders and Stroke and the National Institute of Allergy and Infectious Diseases are currently funding research into the cause of GBS as well as treatments; andWHEREAS, The World Health Organization has included GBS in its intersectoral global action plan on epilepsy and other neurological disorders to improve care for conditions like GBS; andWHEREAS, Organizations like GBS-CIDP Foundation International are working to bring greater awareness to GBS; andWHEREAS, "Guillain-Barré Syndrome Awareness Month" is recognized in May in order to raise awareness of GBS and advocate for further research; therefore be itRESOLVED, That the House of Representatives recognize the month of May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.20260HR0526PN3411 - 2 - 1234567891011121314151617181920212223242526
under the
same topic PRINTER'S NO. 3411 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.526 Session of 2026 INTRODUCED BY BELLMON, HOHENSTEIN, GIRAL, McNEILL, HILL-EVANS, VENKAT, KHAN, WAXMAN, SANCHEZ, NEILSON, CIRESI, GALLAGHER AND CEPEDA-FREYTIZ, MAY 13, 2026 REFERRED TO COMMITTEE ON HEALTH, MAY 14, 2026 A RESOLUTIONRecognizing the month of May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.WHEREAS, Guillain-Barré syndrome (GBS) is a rare acute autoimmune condition which affects an individual's peripheral nerves; andWHEREAS, GBS was first described in 1916 by scientists Guillain, Barré and Strohl and was believed to primarily affect the limbs; andWHEREAS, GBS is classified as an autoimmune disease due to the fact that the immune system attacks healthy nerves and damages them; andWHEREAS, GBS affects 3,000 to 6,000 people annually in the United States, according to the United States Centers for Disease Control and Prevention; andWHEREAS, GBS can affect anyone, however the disease typically affects male adults over 50 years of age; andWHEREAS, While the cause of GBS is not fully understood, 1234567891011121314151617 symptoms typically start shortly after a respiratory or gastrointestinal bacterial or viral infection; andWHEREAS, GBS is not contagious and is characterized by a rapid onset of symptoms, which typically increase in severity over the course of the syndrome; andWHEREAS, Due to the risk of muscle paralysis, GBS usually requires hospitalization; andWHEREAS, Those with GBS are typically able to fully recover with immunotherapy treatments and rehabilitation; andWHEREAS, The National Institutes of Health's National Institute of Neurological Disorders and Stroke and the National Institute of Allergy and Infectious Diseases are currently funding research into the cause of GBS as well as treatments; andWHEREAS, The World Health Organization has included GBS in its intersectoral global action plan on epilepsy and other neurological disorders to improve care for conditions like GBS; andWHEREAS, Organizations like GBS-CIDP Foundation International are working to bring greater awareness to GBS; andWHEREAS, "Guillain-Barré Syndrome Awareness Month" is recognized in May in order to raise awareness of GBS and advocate for further research; therefore be itRESOLVED, That the House of Representatives recognize the month of May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.20260HR0526PN3411 - 2 - 1234567891011121314151617181920212223242526
Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.